Libre, Floren C.

HRN: 28-25-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/14/2025
12/21/2025
IV
4.5g
Q8H
Typhoid Fever; CAP (still With Recurrent Fever,cough And Occasional Dyspnea At Ceftriaxone D6-7)
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: